The Nutshell

» culture, policy and cancer

Daily News Roundup

Most Recent

image: Novartis Drops Gene Therapy Research

Novartis Drops Gene Therapy Research

By | September 6, 2016

The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.

1 Comment

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

image: Stem Cells Drive Cancer Risk in Mice

Stem Cells Drive Cancer Risk in Mice

By | August 26, 2016

Mutations that arise during stem cell division contribute to the development of cancers in a variety of organs, according to a study.

0 Comments

image: Seven More Retractions for Cancer Researcher

Seven More Retractions for Cancer Researcher

By | August 10, 2016

All of the papers had been published in the Journal of Biological Chemistry.

1 Comment

Science advocacy organizations have drafted a list of 20 questions for Hillary Clinton, Gary Johnson, Jill Stein, and Donald Trump; will post responses as they roll in.

0 Comments

image: Wolf Species Are Part Coyote

Wolf Species Are Part Coyote

By | July 28, 2016

Genomic analysis reveals wolves and coyotes have hybridized, potentially complicating wolves' protection under the US Endangered Species Act.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech